Antisynthetase syndrome treated with tocilizumab

Joint Bone Spine. 2016 May;83(3):361-2. doi: 10.1016/j.jbspin.2015.03.016. Epub 2015 Oct 23.

Authors

Amandine Beaumel¹, Olivier Muis-Pistor², Jacques-Guy Tebib², Fabienne Coury²

Affiliations

¹ Department of Rheumatology, centre hospitalier Lyon Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France; University of Lyon I, 69007 Lyon, France. Electronic address: amandine.beaumel@chu-lyon.fr.
² Department of Rheumatology, centre hospitalier Lyon Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France; University of Lyon I, 69007 Lyon, France.

PMID: 26471411
DOI: 10.1016/j.jbspin.2015.03.016

No abstract available

Keywords: Antisynthetase antibodies; Antisynthetase syndrome; Immunosuppressive treatment; Polyarthritis; Polymyositis; Tocilizumab.

Publication types

Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / therapeutic use
Female
Humans
Myositis / drug therapy*
Syndrome

Substances

Antibodies, Monoclonal, Humanized
tocilizumab

Supplementary concepts

Antisynthetase syndrome